Recombinant interferon alpha-2b in the management of malignant pleural effusions

Chest

Volumn 111, Issue 6, 1997, Pages 1597-1599

  Wilkins III, Harry E ^a,b   Connolly, Mark M ^a   Grays, Peter ^a   Marquez, Guillermo ^a   Nelson, Darren ^a  

^a Department of Surgery   (United States)

^b NONE   (United States)

Author keywords

Interferon; Intrapleural therapy; Malignant pleural effusion

Indexed keywords

BLEOMYCIN; CHLORMETHINE; FLUOROURACIL; MEPACRINE; RECOMBINANT ALPHA2B INTERFERON; TETRACYCLINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; HUMAN; HYPOTENSION; INTRAPLEURAL DRUG ADMINISTRATION; LEUKOPENIA; LUNG CANCER; MALE; NAUSEA; PAIN; PLEURA EFFUSION; PLEURA METASTASIS; PRIORITY JOURNAL; SCLEROTHERAPY;

EID: 0030926261     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1597     Document Type: Article

References (17)

1. Hood RM. Surgical discuses of the pleura and chest wall. Philadelphia: Saunders, 1986; 57-77
2. Gibbon's surgery of the chest. 4th ed. Philadelphia: Saunders, 1983; 372-80
3. Ruckdeschel JC. Management of malignant pleural effusion: an overview. Semin Oncol 1988; 15:324-28
4. Manck PM. Treatment of malignant pleural effusions. In: DeVita VT. ed. Cancer: principles and practice of oncology. Philadelphia: JB Lippencott, 1982: 1568-71
5. Paladine W, Cunningham TJ, Sponzo R, et al. Intracavitary bleomycin in the management of malignant effusions. Cancer 1976; 38:1903-08
6. Ostrowski MJ. Intracavitary therapy with bleomycin for the treatment of malignant pleural effusions. J Surg Oncol 1989: 1(suppl):7-13
7. Fracchia AA, Knapper WH, Carey JT, et al. Intrapleural chemotherapy for effnsion from metastatie breast carcinoma. Cancer 1970; 26:626-29
8. Fentiman IS, Rubens RD, Hayward JL. Control of pleural effusions in patients with breast cancer: a randomized trial. Cancer 1983; 52:737-39
9. Ohri SK, Oswal SK, Townsend ER,. et al. Early and late outcome after diagnostic thoracoscopy and talc pleurodesis. Ann Thorac Surg 1992; 53:1038-41
10. Webb WR, Ozmen V, Moulder PV, et al. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg 1992; 103:881-88
11. Aelony Y. Thoracoscopic talc poudrage: comparison with tetracycline and use in Hodgkin's disease [communication to the editor]. Chest 1992; 102:1922-23
12. Chambers JS. Talc as a pleural sclerosant [correspondence]. Br J Surg 1991; 78:1401
13. Cascinu S, Isidori PP, Fedeli A, et al. Experience with intrapleural natural beta interferon in the treatment of maligant pleural effusions. Tumori 1991; 77:237-38
14. Rosso R, Rimoldi R, Salvati F, et al. Intrapleural natural beta interferon in the treatment of malignant pleural effusions. Oncology 1988; 45:253-56
15. Jereb B, US-Krasovec M, Cervek J, et al. Intrapleural application of human leukocyte interferon (HLI) in breast cancer patients with ipsilateral pleural carcimomatosis. J Interferon Res 1987; 7:357-63
16. Goldman CA, Skinnider LF, Maksymiuk AW. Interferon instillation for malignant pleural effusions. Ann Oncol 1993; 4:141-45
17. Davis M, Williford S, Muss HB, et al. A phase I-II study of recombinant intrapleural irai alpha interferon in malignant pleural effusions. Am J Clin Oncol 1992; 15:328-30